Non-small cell lung cancer is a condition wherein malignant cells (cancer-forming cells) develop inside the lung tissues. Smoking is the primary cause of non-small cell lung cancer. Symptoms include blood in cough and breathing difficulties. A lung biopsy is done to arrive at the diagnosis. Non-small cell lung cancer is treated by immunotherapy, chemotherapy, radiation, and surgery.
Non-Small Cell Lung Cancer: Symptoms, Stages, Treatment
Non-small cell lung cancer makes up 80 to 85 percent of lung cancer cases. Learn its types, stages, treatment options, and survival outlook in detail.
Targeted Therapy Advancements: A Precise Approach in Lung Cancer Treatment
Targeted therapy treats lung cancer by targeting specific genetic mutations. And it has fewer side effects than traditional chemotherapy.
What Are the Uses of Lorlatinib?
Lorlatinib is a targeted therapy cancer medicine. It is used in the case of ALK-positive non-small cell lung cancer.
Selpercatinib for Non-Small Cell Lung Cancer
Selpercatinib is used to treat a certain type of non-small cell lung cancer (NSCLC). Read the article to know more.
Adagrasib for Non-Small Cell Lung Cancer
Adagrasib is an anticancer drug for treating non-small cell lung cancer (NSCLC). To know more, read further.
Amivantamab-vmjw - Indications, Dosages, Precautions, and Its Pharmacological Aspects
Amivantamab-vmjw is a bispecific antibody used to treat non-small cell lung cancer. It is used as an injection along with other chemotherapy medicines.
Rehabilitation of Non-small Cell Lung Cancer
Rehabilitation for non-small cell cancer provides faster recovery and emotional support. It also provides an immunity boost and improvement in lung function.
Dacomitinib - Uses, Indications, and Contraindications
Dacomitinib is a drug used in the treatment of non-small cell lung cancer. Read the article below to know more.
Lazertinib - Indications, Contraindications, and Side Effects
Lazertinib is a third-generation tyrosine kinase inhibitor used to treat metastatic or locally advanced NSCLC in adult patients.
Repotrectinib - Dosage, Uses, and Side Effects Overview
Repotrectinib is a kinase inhibitor used in the treatment of non-small cell lung cancer. It blocks ROS1 and NTRK proteins that help cancer cells grow and spread.
